Thrombophilia Risk Assessment

Genetic testing for these 13 gene mutations:

• Leiden factor V mutation;
• Factor II coagulation mutation;
• Beta fibrinogen mutation 455 G/A;
• MTHFR C677T mutation;
• MTHFR 1298 A>C mutation;
• HPA gene (glycoprotein IIIa) polymorphism;
• Coagulation factor V mutation H1299R;
• Apolipoprotein E gene polymorphism;
• ACE gene polymorphism;
• AGT gene (angiotensinogen) mutation;
• Coagulation factor XII polymorphism; - Pal-1 (plasminogen) gene mutation;
• Apolipoprotein B gene mutation R3500Q.

Recommendation on when to perform the test: The test can be performed when planning a pregnancy or at any time during pregnancy and is recommended before starting hormonal contraception.

Sample: Blood.

Execution time after admission to the laboratory: 10 business days.